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ABSTRACT 
 Studies have demonstrated that the oxysterol binding protein (OSBP) acts as a 
phosphatidylinositol phosphate (PIP)-sterol exchanger at membrane contact sites (MCS) of 
the endoplasmic reticulum (ER) and Golgi. OSBP is known to pick up phosphatidylinositol-
4-phosphate (PI(4)P) from the ER, transfer it to the trans-Golgi in exchange for a cholesterol 
molecule that is then transferred from the trans-Golgi to the ER. Upon further examination 
of this pathway by Ridgway et al. (1), it appeared that phosphorylation of OSBP played a 
role in the localization of OSBP. The dephosphorylation state of OSBP was linked to Golgi 
localization and the depletion of cholesterol at the ER. To mimic the phosphorylated state 
of OSBP, the mutant OSBP-S5E was designed by Ridgway et al. (1).  
  The lipid and sterol recognition by wt-OSBP and its phosphomimic mutant OSBP-
S5E were investigated using immobilized lipid bilayers and dual polarization interferometry 
(DPI). DPI is a technique in which the protein binding affinity to immobilized lipid bilayers 
is measured and the binding behavior is examined through real time. Lipid bilayers 
containing 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) and varying concentrations 
of PI(4)Ps or sterols (cholesterol or 25-hydroxycholesterol) were immobilized on a silicon 
nitride chip. It was determined that wt-OSBP binds differently to PI(4)P-containing bilayers 
compared to OSBP-S5E. The binding behavior suggested that wt-OSBP extracts PI(4)P and 
the change in the binding behavior, in the case of OSBP-S5E, suggested that the 
phosphorylation of OSBP may prevent the recognition and/or extraction of PI(4)P.  
In the presence of sterols, the overall binding behavior of OSBP, regardless of 
phosphorylation state, was fairly similar. The maximum specific bound mass of OSBP to 
sterols did not differ as the concentration of sterols increased. However, comparing the 
maximum specific bound mass of OSBP to cholesterol with oxysterol (25-
hydroxycholesterol), OSBP displayed nearly a 2-fold increase in bound mass. With the 
absence of the wt-OSBP-PI(4)P binding behavior, it can be speculated that the sterols were 
not extracted.  
In addition, the binding behavior of OSBP was further tested using a fluorescence 
based binding assay. Using 22-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-23,24-bisnor-
5-cholen-3β-ol (22-NBD cholesterol), wt-OSBP a one site binding dissociation constant Kd, 
of 15 ± 1.4 nM was determined. OSBP-S5E did not bind to 22-NBD cholesterol and Kd 
value was not obtained.  
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1. INTRODUCTION 
1.1. Lipids 
 Lipids are a group of naturally occurring molecules that include fats, sterols, 
glycerides, phospholipids and more (Figure 1) (2). With various biological functions, lipids 
have important roles in energy storage, as structural components of membranes, in cell 
signaling, and more (3). Although the majority of lipids are categorized as hydrophobic 
molecules, there are some lipids, such as phospholipids, that are categorized as amphiphilic. 
The amphiphilic nature of phospholipids allows them to form unilamellar/multilamellar 
vesicular membranes. Small unilamellar vesicles (SUVs) can range up to 100 nm in size (3). 
Phospholipids, more precisely glycerophospholipids, similar to glycerides, possess a 
glycerol backbone esterified to fatty acid chains. However, unlike triglycerides, 
phospholipids possess a phosphate group and a head group, e.g. choline in the case of 
phosphatidylcholine (PC), instead of the third fatty acid chain, giving them their amphiphilic 
property (Figure 2) (4). Cellular membranes consist mostly of double layered phospholipids 
arranged in such a way that the acyl chains of the fatty acids are facing each other on the 
inside and the head groups are facing the outside on both surfaces (3).  
 The first phospholipid, identified by Gobley from the egg yolk of chickens, was 
lecithin or phosphatidylcholine (PC) (5). Due to the structure of choline, PC becomes 
zwitterionic, hence characterizing PC as a neutral phospholipid (Figure 3) (6). Other 
common phospholipids exist in a net anionic form due to the lack of charge in the substituent 
to the head group, such as in the case of phosphatidylinositol (PI) (Figure 3) or the charged 
but net neutral head group of phosphatidylserine (PS) (6). Studies involving phospholipids 
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have commonly incorporated the use of unsaturated fatty acid chain lipids, such as 1,2-
dioleoyl-sn-glycero-3-phosphocholine (DOPC) instead of the most prevalent PC lipid 
(Figure 4) (7).  
 
Figure 1: The chemical structures and IUPAC names of the triglyceride stearin, the 
phospholipid PC and the sterol cholesterol (2).  
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Figure 2: The chemical structure of the phospholipid phosphatidylcholine (PC) and its major 
groups (adapted from Featherstone, (4)).  
 
Figure 3: The basic phospholipid chemical structure and its characteristic based on different 
substituents (6).  
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Figure 4: The chemical structure of 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) (7). 
 Cellular membranes vary in phospholipid content and composition from one cell to 
another. In fact, membranes within the cell also vary. Although the phospholipid 
composition of the membranes is known, the influence this composition has on cellular 
properties is not completely understood. The current hypotheses proposed are that certain 
cells and proteins require specific membranes in order to maintain functional properties (8). 
Mammals contain a high proportion (40-80% of dried cell weight) of phospholipids (8). The 
major phospholipids in mammalian membranes are phosphatidylcholine (PC), followed by 
phosphatidylethanolamine (PE) (8). Other lipids such as cholesterol and sphingomyelin are 
also found in plasma membranes (8). For example, the amount of cholesterol present in the 
endoplasmic reticulum (ER) membrane is 3-6% of total lipids (9).  
 Whilst the ER membrane is poor in cholesterol, the ER is also the location where 
cholesterol is synthesized (10). This is indicative that this sterol is being transferred by some 
means to nearby compartments. Studies have shown that the oxysterol binding protein 
(OSBP) transfers cholesterol, and the oxidized sterol 25-hydroxy cholesterol (oxysterol) 
(Figure 5), between the ER and the Golgi (10). This process is coupled with 
phosphatidylinositol-4-phosphate (PI(4)P) exchange at membrane contact sites (MCSs) 
(10).  
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Figure 5: The chemical structure of cholesterol in comparison to its oxidized form 25-OH 
cholesterol (2).  
 
1.2. Membrane Contact Sites (MCS) 
 Membrane contact sites (MCS) are narrow cytoplasmic gaps in which organelles 
come to close proximity, around 30 nm or less (11; 12). With close proximity, organelles 
can exchange relatively small molecules such as ions and simple lipids between two 
compartments. MCS can be involved in various processes including regulation of immune 
response, apoptosis, organelle dynamics and much more (11). On a molecular level, MCS 
are involved with calcium (Ca2+) and/or lipid exchange between compartments mainly 
around the ER (11). The ER is the main site of lipid synthesis and the main storage of cellular 
Ca2+ (11).  
 Starting with calcium signaling, the concentration of Ca2+ in the ER is 106 times 
greater to that of the concentration of Ca2+ in the cytosol (the ER concentration is in the 
millimolar range while the cytosol concentration is in the nanomolar range) (13). The 
difference in the concentration of calcium and the presence of SERCA 
(Sarcoplasmic/Endoplasmic Reticulum Ca2+ ATPases which pump Ca2+ into the ER) and 
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PMCA (Plasma Membrane Ca2+ ATPases which pump Ca2+ out of the cell) creates a 
gradient that is used in signaling events by activating downstream Ca2+-binding proteins 
using Ca2+ channels (example the Ranodine Receptors (RyR)) (11; 13). Examples of such 
events include processes of memory, vision, muscle contraction, immune response and 
much more (13). In addition and on a smaller scale, cytosolic microdomains are formed with 
slow Ca2+ diffusion, where the concentration of Ca2+ differs to that of the bulk cytosol (11). 
Microdomains are created at MCS in which coordinate the majority of the Ca2+ movements 
across different compartments (11).  
 Lipid exchange is prominent at the ER where most lipids are synthesized. Some 
lipids, such as cholesterol and ceramide can be transported even in the absence of a vesicular 
transport system (12). MCS is thought to play a role in facilitating lipid exchange between 
paired organelles by ensuring the specificity and efficacy of the lipid exchange (11; 14). In 
a non-vesicular transport system, lipids are transported via lipid transport proteins (LTP), 
such as in the example of OSBP which interacts with MCS of the ER (11).  The LTP OSBP 
is able to extract one lipid molecule from one membrane and transfer it to another; in this 
case PI(4)P is extracted from the ER and transferred to the Golgi (11). LTPs are known to 
have domains that tend to interact with different membranes; in the case of OSBP, OSBP 
has a PH (Pleckstrin Homology) domain that interacts with PI(4)P at the Golgi and a FFAT 
motif that interacts with VAP-A at the ER (more detail on the domains of OSBP and OSBP 
pathway is explained in the upcoming sections) (11; 15). LTPs’ targeting domains are 
directed to MCS of different membranes and it is believed that MCS provides specificity to 
the LTP’s binding to lipid membranes.  
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1.3. OSBP-Related Proteins (ORP) 
 ORPs are a family of cytosolic lipid transfer proteins that were found after the 
discovery of the OSBP (16). In addition to their lipid binding and transfer ability, ORP 
proteins have an affinity for cholesterols and oxysterols (17). ORP proteins are identified by 
their OSBP fingerprint sequence EQVSHHPP, identified in yellow in the figures below 
(Figure 6 and 9) (18; 19). The most common feature of ORP proteins is the sterol binding 
domain (SBD), also known as the OSBP related domain (ORD) (17). ORD is a β-barrel 
sterol-binding domain that is conserved from yeast to humans (17; 20). Other domains that 
may be found in ORPs are the Pleckstrin Homology (PH) domain that is responsible for 
sensing and binding to the phospholipid PI(4)P, FFAT (two phenylalanines in an acidic 
tract) that is responsible for sensing and binding to vesicle associated proteins (VAP) located 
at the ER, GOLD (Golgi domains) and ankyrin repeats (21). Since the discovery of OSBP, 
a total of 12 proteins have been associated with ORP family of proteins (20). The yeast 
homologues of OSBP, the Osh family of proteins, have been extensively studied in order to 
better understand the behavior of the sterol binding proteins.    
1.3.1. Yeast OSBP Homologue Osh4p/Kes1p 
 The yeast S. cerevisiae has seven OSBP homologues (Osh1p-Osh7p) (17). In 
addition to all Osh proteins having an OSBP fingerprint sequence and the ORD, a few 
(Osh1p-Osh3p) have a Pleckstrin Homology (PH) domain (Figure 6) (19). The simplest and 
most studied homologue is Osh4p/Kes1p. Due to the inability of crystallizing the human 
OSBP, Osh4p was isolated and crystallized by Im et al. at 1.5-1.9 Å resolution (Figure 7) 
(21). The structure of Osh4p is built around a β-barrel center that consists of 19 antiparallel 
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β-sheet strands (residues 115-293) (Figure 7) (21). The structure of the β-barrel is oriented 
in a way that allows the protein to have a hydrophilic exterior and a hydrophobic tunnel on 
the interior (21). The N-terminal (residues 1-29) act as a lid that remains unfolded leaving 
the barrel pocket open when the protein is without a ligand (21). Upon sterol binding, the 
lid closes and the sterol becomes bound in a head-down orientation in which the hydroxyl 
group of the sterol is buried at the bottom of the barrel (21). This, in accordance with non-
vesicular transport, is how sterols move from plasma membrane (PM) to ER (22). 
Investigations have shown that Osh4p is capable of sterol transport among cellular 
compartments and is, in fact, regulated by phosphoinositides, specifically 
phosphatidylinositol-phosphates (PIPs) (22; 23).  
 
Figure 6: Sequence alignment of Osh proteins displaying ORD (red), OSBP fingerprint 
(yellow), PH domain (blue), GOLD domain (purple) and ankyrin-like repeats (orange) (19).  
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Figure 7: Ribbon protein structure of Osh4p/Kes1p displaying N-terminal lid (red), central 
helix (orange), C-terminal region (blue), β-barrel (green) and ergosterol (yellow) (21).  
 Osh4p does not have a specific phosphatidylinositol phosphate-binding domain (23). 
Studies have shown that ORPs, including Osh4p, can in fact bind to PIPs through ORD (24; 
25). In vitro binding assays have shown that Osh4p is unable to distinguish PI(4)P from 
PI(4,5)P2-containing membranes (23; 26). Originally, sterol uptake by Osh4p was believed 
to be regulated by PI(4,5)P2, a plasma membrane (PM) lipid. However, this became hard to 
accept as genetic and cellular studies have shown that Osh4p has a specific role at the Golgi 
and that its sterol uptake was in fact regulated by PI(4)P, a Golgi lipid located on the trans 
side of the Golgi (25). The sterol/PI(4)P regulation became evident as a sterol/PI(4)P 
exchange pathway was proposed (Figure 8) (23).  
 The interaction of Osh4p with the anionic trans-Golgi membrane opens the lid of the 
ORD promoting the release of the sterol in exchange for a PI(4)P (Figure 8) (23). 
Consequently, Osh4p then transfers PI(4)P from the trans-Golgi to the ER where another 
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sterol will be extracted as an exchange, and the lipid/sterol exchange/transfer pathway 
continues for another round (Figure 8) (23). This cycle is proposed in parallel with the work 
of Sac1p/Pik1p and Sec14p. The phosphatase Sac1p dephosphorylates PI(4)P into PI and 
the kinase Pik1P phosphorylates PI into PI(4)P through the consumption of ATP (Figure 8) 
(23). The cycling of the lipids PI/PC between the ER and Golgi is done by the transfer 
protein Sec14p (Figure 8) (23). The human OSBP is believed to have a somewhat similar 
yet more complex PI(4)P/sterol exchange pathway.  
 
Figure 8: Proposed PI(4)P-sterol exchange pathway for the Osh4p (23). With an open lid, 
Osh4p picks up ergosterol from the ER membrane, closes its lid and transfers the sterol to 
the trans-Golgi membrane (23). At the trans-Golgi membrane, Osh4p exchanges ergosterol 
with PI(4)P where this lipid is transferred to the ER membrane and is exchanged for another 
ergosterol (23). This cycle is coupled with the dephosphorylation of PI(4)P into PI by Sac1p, 
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the phosphorylation of PI into PI(4)P through the consumption of ATP by Pik1p, and the 
exchange and transfer of PI and PC lipids by the protein Sec14p (23). 
 
1.3.2. Oxysterol Binding Protein (OSBP) 
 Human family members of ORPs are arranged into six subfamilies all of which 
possess the OSBP fingerprint sequence as well as the ORD (18). The majority of these 
proteins also possess a Pleckstrin Homology (PH) domain that plays a role in its binding 
and recognition of phosphatidylinositol-4-phosphates (PI(4)P) and a FFAT motif that binds 
to vesicle associated membrane protein (VAMP) VAP-A (Figure 9) (27; 18). OSBP (PI(4)P 
transporter) and other lipid transport proteins such as CERT (a ceramide transporter), 
FAPP2 (glucosylceramide transporter), Sec14 (phosphatidylinositol transporter) are found 
near the membrane contact sites (MCSs) between the Golgi and the ER (15; 20; 28; 29; 30). 
Except for Sec14, the previous mentioned proteins all share a common PH domain that helps 
recognize the Golgi membrane and a FFAT motif that helps recognize the ER membrane 
(31). Since OSBP contains PH and FFAT motifs, and can be located near the ER/Golgi, 
MCSs researchers have proposed that this protein tethers to both ER and Golgi during a 
proposed mechanism for sterol/PI(4)P exchange (Figure 10 and 11) (15).  
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Figure 9: Sequence alignment of human OSBP/ORP proteins displaying ORD (red), OSBP 
fingerprint (yellow), PH domain (green), ankyrin-like repeats (blue), VAP targeting motif 
(FFAT motif) (black) and trans-membrane domain (orange) (18). L and S represent long 
and short variants respectively (18).  
 
13 | P a g e  
 
 
Figure 10: Proposed PI(4)P-sterol exchange pathway for the OSBP (15). Starting with 
membrane tethering, OSBP attaches itself to PI(4)P or ARF1-GTP by the PH domain and 
VAP-A by the FFAT motif. After OSBP tethers the ER/Golgi membranes, cholesterol is 
then extracted from the ER and transferred to the Golgi in which the sterol is exchanged 
with PI(4)P that is transferred to the ER. This proposed mechanism terminates when the 
PI(4)P that was transferred by OSBP is hydrolyzed by the phosphatase Sac1p. Lack of 
PI(4)P in the Golgi membranes would decrease membrane tethering and thus the rate of 
sterol transfer. 
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Figure 11: The organization of OSBP domains between the ER and Golgi (15). OSBP is 
suggested to form a dimeric rod-like structure as deduced from the domains of other related 
proteins: ORP11 PH domain (2D9X), Osh4p ORD domain (1ZHZ), VAP-A-FFAT motif 
complex (1Z9O), Arf1-GTP (1O3Y) and tropomyosin coiled-coil regions (2D3E). The 
tethering of OSBP to both the Golgi and ER membranes is done by the PH domain’s 
attachment to ARF1-GTP and the FFAT motif’s attachment to VAP-A (15). 
 The proposed PI(4)P/sterol exchange pathway for OSBP can be broken into four 
steps: membrane tethering, cholesterol transport, PI(4)P transport, and PI(4)P hydrolysis 
(Figure 10) (15). The rate limiting step of the PI(4)P/sterol exchange pathway is the 
hydrolysis of PI(4)P by Sac1p (15). This ensures that the pathway is irreversible and when 
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PI(4)P is limiting, the protein is signaled to end the tethering of the membranes (15).  
Membrane tethering is initiated upon the recognition of PI(4)P or ARF1-GTP by the PH 
domain and VAP-A by the FFAT motif of OSBP (15; 32; 33). OSBP is suggested to form a 
dimeric rod-like structure as deduced from the domains of other related proteins: ORP11 
PH domain (2D9X), Osh4p ORD domain (1ZHZ), VAP-A-FFAT motif complex (1Z9O), 
Arf1-GTP (1O3Y) and tropomyosin coiled-coil regions (2D3E) (Figure 11) (15). After 
OSBP tethers the ER/Golgi membranes, cholesterol is then extracted from the ER and 
transferred to the Golgi. OSBP’s ability to transfer sterols has been debated as Osh/ORP 
proteins have not been able to transfer sterols fast enough to account for the quick 
redistribution of cholesterol between organelles (34). However, Mesmin et al. were able to 
show a “maximal turnover rate of 0.5 s-1, or 30 dehydroergosterols (DHE) transferred per 
OSBP per minute” (15). After the transfer of cholesterol from the ER to the Golgi by OSBP, 
OSBP exchanges cholesterol for a PI(4)P. Such an exchange was evident with Osh4p (23). 
This proposed mechanism terminates when the PI(4)P that was transferred by OSBP is 
hydrolyzed by the phosphatase Sac1p. Lack of PI(4)P in the Golgi membranes would 
decrease membrane tethering and thus the rate of sterol transfer. However, details about the 
rates of the hydrolysis of PI(4)P by Sac1p are still under investigation. Sac1p was originally 
shown to hydrolyze PI(4)P in trans-Golgi, which meant that (based on the proposed 
hypothesis) OSBP will have to competitively bind to PI(4)P with Sac1p; but the current 
proposed pathway can only be effective if the Sac1p works in cis-Golgi or if Sac1p cycles 
between ER and Golgi, as OSBP transfers PI(4)P from trans to cis membrane (35). Mesmin 
et al. have argued that by positioning the Sac1p at the trans location, the cellular distribution 
of PI(4)P is not affected nor does it promote the hydrolysis of PI(4)P (15). Furthermore, 
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Mesmin et al. have demonstrated that Sac1p works in cis location reinforcing their current 
proposed lipid/sterol exchange/transfer OSBP pathway (15). Aside from the proposed sterol 
exchange/transfer OSBP pathway, OSBP is also subject to phosphorylation which may also 
control the directionality of its activity.  
1.4. Protein Phosphorylation 
 Many proteins undergo post-translational phosphorylation through the action of 
protein kinases at the consumption of ATP (36).  Removal of the phosphate group is 
accomplished by phosphatase enzymes (36). In order to phosphorylate a protein, the amino 
acids serine, threonine, tyrosine, histidine, arginine and lysine residues are targeted (37). 
Kinases share a catalytic domain that catalyze the transfer of the gamma-phosphate of ATP 
to one of the targeted amino acid residues such as serine (38). Protein kinases are regulated 
by various mechanisms including but not limited to the control of their phosphorylation state 
(38). In addition, protein phosphorylation plays multiple roles in signalling pathways and 
cellular processes, many of which are regulatory processes (36). For example, in the first 
step of glycolysis and in order to initiate glycolysis, glucose is phosphorylated by 
hexokinase to form glucose-6-phosphate (G6P) at the consumption of ATP (39). This can 
be reversed by the enzyme glucose-6-phosphatase in which G6P is hydrolyzed to glucose 
and orthophosphate (39).  
 Returning to the topic of phosphorylation of OSBP, the phosphorylation cycle of 
OSBP has been linked to Golgi localization and the cholesterol/SM (sphingomyelin) content 
of cells (1). Although the ER is the location of where cholesterol is synthesized, the rapid 
transfer of cholesterol to the Golgi makes the ER a cholesterol-poor environment. Since the 
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ER is poor in cholesterol compared to the Golgi, OSBP needs a mechanism that allows it to 
deliver cholesterol against a concentration gradient, hence OSBP undergoes a rapid 
phosphorylation cycle that is linked to Golgi localization and the cholesterol content in the 
ER (27; 40). Therefore, depletion of cholesterol at the ER causes OSBP dephosphorylation 
and Golgi localization (27; 40).   
 In order to better understand the effect of the phosphorylation cycle on OSBP’s 
transfer/exchange activity, Goto et al. designed OSBP phosphomutants in order to study 
their effects on the transfer/exchange OSBP pathway (27). OSBP has two sites in which 
serine repeats can be phosphorylated (Figure 12) (27). The serine (S) to glutamic acid (E) 
mutation is to mimic the phosphorylation at these sites by installing permanently anionic 
glutamate groups (Figure 13) (27). Focusing primarily on the phosphomimic OSBP-S5E, in 
which five serine residues were mutated to glutamic acid residues, Goto et al. demonstrated 
that this mutant has increased sterol binding capacity, higher cholesterol extraction, but 
reduced transfer activity and the binding of PI(4)P was not affected (27). Better 
understanding the work of this mutant can help fully understand the phosphorylation cycle 
of OSBP to the OSBP sterol/lipid transfer/exchange pathway.  
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Figure 12: Mutations at different phosphorylation sites of OSBP (27). OSBP has two 
possible sites of phosphorylation. In order to mimic the properties of the phosphorylation 
state of OSBP, glutamic acid (E) residues replaced serine (S) residues; such was the case in 
OSBP-S5E where 5 serine residues were replaced by glutamic acid residues.  
 
Figure 13: The chemical structure of phosphorylated serine in comparison to glutamic acid 
(27). Glutamic acid residues were used to mimic the anionic properties of the 
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phosphorylated serine residues. This was used in the design of OSBP-S5E mutant in which 
5 serine residues were mutated to glutamic acid residues (27). 
1.5. Overview of Project 
The objective of this thesis is to examine the role of OSBP phosphorylation on 
sterol/lipid binding and extraction. Phosphorylation of OSBP has been linked to OSBP’s 
localization to the Golgi and the cholesterol/SM content of the cells. Depletion of 
cholesterol, by inhibition, at the ER results in dephosphorylation of OSBP and Golgi 
localization (27; 40). OSBP’s localization to the Golgi may be part of the current OSBP 
proposed pathway (15). The phosphorylation cycle of OSBP is showing potential as a means 
of control in the directionality and/or specificity of the transfer activity.  
The role of OSBP phosphorylation will be studied via protein-lipid binding assays 
and fluorescent based assays. The protein-lipid binding assays will be examined through 
dual polarization interferometry (DPI). DPI is an analytical technique capable of measuring 
protein adsorption to phospholipid bilayers that are immobilized on a silicon oxynitride 
sensor surface (41). Small unilamellar vesicles (SUVs) mimicking the Golgi/ER membranes 
will be constructed and used. SUVs will include a high concentration of the DOPC lipid 
with/without variable concentrations of the phospholipid PI(4)P or the sterols cholesterol 
and 25-hydroxycholesterol. Using DPI, the real-time behavior of the binding kinetics of 
OSBP to different compositions of lipid membranes will be examined.  
In addition, the role of OSBP phosphorylation will be examined through 
fluorescence binding assays. The ability of OSBP to bind cholesterol will be studied using 
the cholesterol analogue 22-NBD-cholesterol through a fluorescence based binding assay. 
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The ultimate goal of this thesis is to evaluate the role of OSBP phosphorylation on 
sterol/phospholipid binding. The binding kinetics of OSBP-S5E with sterol/PI(4)P 
containing membranes will be analyzed in comparison to wt-OSBP.  
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2. MATERIALS AND METHODS 
2.1. Consumable Products 
 50 mL Falcon tubes 
 Amicon Ultra Centrifugal Filters (Ultracel – 50K) 
AnaLight Bio 200 FB80 chips 
 Avestin Polycarbonate Membrane – 100 nm 
Bio-Rad Macro-Prep DEAE Support Weak Anion Exchange Support 
 T-25 flasks 
2.2. Chemical Reagents and Solutions 
2.2.1. Enzymes, Antibiotics and Lipids 
10,000 U/mL Penicillin-Streptomycin (Life Technologies/ThermoFisher Scientific, 
Burlington) 
 25-OH Cholesterol (Oxysterol) (Avanti Polar Lipids, Alabama) 
Cholesterol (Avanti Polar Lipids, Alabama) 
 Complete Tablets Mini EDTA-free EASYpack – protease inhibitor cocktail tablets 
(Roche, Sigma-Aldrich Co., Canada) 
DOPC (1,2-dioleoyl-sn-glycero-3-phosphocholine) (Avanti Polar Lipids, Alabama) 
22 | P a g e  
 
Fungizone Antimycotic (Amphotericin B) (Life Technologies/ThermoFisher 
Scientific, Burlington) 
 NBD-Cholesterol (22-(N-(7-Nitrobenz-2-Oxa-1,3-Diazol-4-yl)Amino)-23,24-
Bisnor-5-Cholen-3β-Ol) (Avanti Polar Lipids, Alabama) 
PI(4)P (phosphatidylinositol-4-phosphate) (Avanti Polar Lipids, Alabama)  
2.2.2. Baculovirus and Insect Cells 
 OSBP-wt Baculovirus liquid sample with measured titre was supplied by Dr. Neale 
Ridgway, Dalhousie University, Halifax, NS. Stored at 4°C away from light.  
 OSBP-S5E Baculovirus liquid sample with measured titre was supplied by Dr. Neale 
Ridgway, Dalhousie University, Halifax, NS. Stored at 4°C away from light.  
 The insect cell line Sf21 Cells (Spodoptera frugiperda line 21) (Life 
Technologies/ThermoFisher Scientific, Burlington): 1 x 107 cells in 1 mL Sf-900 III SFM.  
2.2.3. Culture Medium and Buffers 
2.2.3.1. Culture Medium 
 Insect cell culture medium contains (~1 L):  
  1 L Sf-900 III SFM (Spodoptera frugiperda 900 III serum free medium - 
liquid) (Life Technologies/ThermoFisher Scientific, Burlington)  
  5% (50 mL) Fetal Bovine Serum (Life Technologies/ThermoFisher 
Scientific, Burlington) 
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  100 U/mL (10 mL of 10,000 U/mL stock) Penicillin-Streptomycin (Life 
Technologies/ThermoFisher Scientific, Burlington) 
  0.25 µg/mL (1 mL) Fungizone Antimycotic (Amphotericin B) (Life 
Technologies/ThermoFisher Scientific, Burlington) 
2.2.3.2. OSBP Purification Buffers 
 Buffer A (wash buffer): 50 mM NaH2PO4, 300 mM NaCl, pH 7.4 
 Buffer B (elution buffer): 50 mM NaH2PO4, 300 mM NaCl, 250 mM Imidazole, pH 
7.4 
 Cleaning buffer 1: 1% CH3COOH, 1% H3PO4 
    Or 70% EtOH 
    Or 30% IPA 
Cleaning buffer 2: 20 mM NaH2PO4, 1 M NaCl, 0.1 M EDTA, pH 7.4 
 Cobalt solution: 0.2 – 0.3 M CoCl2·6H2O 
 Lysis buffer: 20 mM Tris-HCl, 150 mM NaCl, 1% Triton X-100, pH 7.4 
 Sodium acetate buffer: 50 mM CH3COONa, pH 4.0 
 Storage buffer: 20% EtOH 
2.2.3.3. Sodium Dodecyl Sulphate (SDS) Polacrylamide Gel Electrophoresis Buffers 
 40% Acrylamide/Bis-Acrylamide Solution (Bio-Rad, Toronto) 
24 | P a g e  
 
SDS-PAGE Separating Buffer: 1.5 M Tris-HCl, pH 8.8 
 SDS-PAGE Stacking Buffer: 0.5 M Tris-HCl, pH 6.8 
 6x SDS-PAGE Loading Dye: 0.6 M dithiothreitol (DTT), 350 mM Tris-HCl, 30% 
glycerol, 10% SDS, 0.12% bromophenol blue, pH 6.8 
 10x SDS-PAGE Running Buffer: 250 mM Tris-Cl, 1.92 M glycine, 1% SDS, pH 8.3 
 ProtoBlue Safe staining solution (Colloidal Coomassie G-250 Stain) (National 
Diagnostics, Atlanta, GA, USA) 
 Pre-stained Broad Range Protein Ladder (New England BioLabs, Ipswich, MA, 
USA) 
2.2.3.4. Ion Exchange Chromatography Buffer  
 Running buffer (RB): 50 mM Tris, pH 8.5 
 Salt buffer (SB): 50 mM Tris, 500 mM NaCl, pH 8.5 
2.2.3.5. Dual Polarization Interferometry (DPI) Buffer 
 DPI buffer: 10 mM K2HPO4, 137 mM NaCl, pH 7.4 
2.2.3.6. Fluorescent Based Assay Buffers 
 DPI buffer, same as previously mentioned 
2.3. Equipment and Programs 
 AnaLight Bio 200 
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 AnaLight Explorer Inject software 
AnaLight Explorer software 
Avanti Polar Lipids extrusion apparatus/Hamilton Gastight #1001 
 Beckman Coulter Allegra X-30R Centrifuge – SX4400 Rotor 
 Bio-Rad BioLogic DuoFlow 
Bio-Rad Gel Doc Ez Imager 
 Bio-Rad Image Lab software 
 Bio-Rad – Mini-Protean III apparatus 
 Farfield AnaLight Bio 200 
Fisher Scientific Isotemp incubator 
Harvard Apparatus PHD 2000 Programmable Pump 
New Brunswick Scientific Co. Incubator Shaker – Series I26 
New Brunswick Scientific Co. Incubator Shaker – Series 25 
Photon Technology International (PTI) Fluorometer 
 Photon Technology International (PTI) software 
 QSonica Sonicators 
 SterilGARD Hood – the Baker Company, Inc. (biological safety cabinet) 
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 Thermo Scientific Sorvall Centrifuge – SS-34 Rotor 
 Zeiss microscope 
2.4. Experimental Protocols 
2.4.1. Growth of Sf21 Cells 
Commercially supplied frozen stocks of Sf21 cells (1 mL, 1 x 108 cells/mL) were 
thawed on ice. Prior to complete thawing of cells, the cells were transferred to a T-25 flask. 
The cell culture was left for 15 minutes to let the cells settle and form a monolayer adherent 
to the flask. The flask was turned to an upright position in which the liquid medium and 
floating cells were discarded, and 2 mL of fresh culture medium (pre-heated at 37°C) was 
added. The monolayer cell culture was then placed in an aerated sterile incubator set to 28°C.  
Monolayer cultures were grown for 3-4 days until they became 80-90% confluent. 
At this stage, the monolayer culture was sub-cultured in a biosafety cabinet. Without shaking 
the flask, the Sf21 monolayer culture was transferred into the biosafety cabinet hood. While 
in an upright position, the culture medium including the floating cells was transferred into 
the waste tube. Two milliliters of new culture medium (pre-heated at 37°C) was added into 
the monolayer culture and the flask was closed. The flask was then tapped hard on its sides 
to dislodge the cells. At times, since the cells do attach very tightly, it was necessary to shake 
the flask vigorously. 0.5 mL of the culture was transferred into a sterile 1 mL microfuge 
tube and the cell density and viability were determined using a hemocytometer and 0.4% 
trypan blue solution. Another 0.5 mL of the culture was then transferred into a new T-25 
flask followed by an addition of 1.5 mL culture medium to it. The last 1 mL of culture was 
transferred to waste.  
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After a minimum of two monolayer generations have passed, the 1 mL culture that 
is usually transferred to waste is now transferred to a 250 mL Erlenmyer flask, followed by 
addition of 24 mL of culture medium (pre-heated to 37°C). This culture was put into a shaker 
incubator (New Brunswick Scientific Co. Incubator Shaker Series 25) set to 28°C and 140-
160 rpm. The suspension culture was then left to grow for another 4-5 days. The cell density 
and viability was then determined using a hemocytometer and 0.4% trypan blue solution. 
The suspension culture was then sub-cultured to a 1 L Erlenmyer flask containing ~250 mL 
culture medium (pre-heated at 37°C) in which 5-10 mL of the culture was transferred using 
a Pasteur pipette in the biosafety cabinet. The new suspension culture was left to grow in a 
shaker incubator (New Brunswick Scientific Co. Incubator Shaker Series 25) set to 28°C 
and 140-160 rpm for 4 days. Following the growth of the cells, the cell density and viability 
was then determined using a hemocytometer and 0.4% trypan blue solution. If the cell 
density is between 1 x 106 to 2 x 106 cells/mL, the cells were determined to be ready for 
infection. If the cell density was lower than that, the suspension culture was left to grow for 
another day, or sub-cultured into a new flask for a new suspension culture.  
2.4.2. Preparation of Sf21 Freeze Stock Cultures 
 After a minimum of 5 monolayer culture generations have passed with a healthy and 
similar pattern of growth, the 1 mL culture that was transferred to waste or culture medium 
to start a suspension sub-culture was now transferred to a 1 mL cryovial to prepare a freeze 
stock culture. DMSO was added to a final concentration of 10%. The cryovial was stored 
for preservation at either -80°C or liquid nitrogen.  
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2.4.3. Baculovirus Infection of Sf21 Cells (Expression of OSBP and Baculovirus) 
 After the suspension culture reached an appropriate cell density between 1 x 106 
cells/mL and 2 x 106 cells/mL, a total of 1.8 x 106 cells were transferred to a Falcon tube. 
The cells were centrifuged at 4000 x g using Rotor  Beckman Coulter Allegra X-30R 
Centrifuge – SX4400 Rotor for 5 minutes and the medium was transferred to waste. OSBP 
construct-containing baculovirus was added to an MOI of 1.5 and the volume was brought 
up to 25 mL using culture medium (pre-heated to 28°C). The infected cells were covered 
with tin foil and thoroughly mixed using a bench top rotator for one hour. After that, the 
cells were transferred to a 1 L Erlenmeyer flask containing 225 mL of culture medium (pre-
heated at 28°C). The flask was transferred to a shaker incubator (New Brunswick Scientific 
Co. Incubator Shaker Series 25) set to 28°C and 140-160 rpm for 3-4 days, which the cells 
were observed under a microscope and monitored daily for an increase in the cell diameter 
size. Once the diameter of the cells increased to 1.5 – 2 times the original size, the cells were 
then pelleted at 4000 x g using the Beckman Coulter Allegra X-30R Centrifuge – SX4400 
Rotor for 5 minutes. The supernatant was saved and filtered for use as baculovirus in which 
its titre was determined using plaque assays, a technique that counts the number of plaque 
forming units on Sf21 baculovirus-infected cells plugged with agar. The pellets were stored 
at -80°C.  
2.4.4. Preparation of Resin for Column Chromatography 
 20 mL of immobilized-metal affinity chromatography (IMAC) uncharged resin was 
transferred to a 50 mL Falcon tube and spun at 4000 x g for 5 minutes using the Beckman 
Coulter Allegra X-30R Centrifuge – SX4400 Rotor. The ethanol supernatant was discarded 
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and 40 mL of sodium acetate buffer (50 mM) was added. The resin was shaken vigorously, 
spun on a rotator for few minutes until the resin was thoroughly mixed. The resin was 
centrifuged at 4000 x g for 5 minutes and the supernatant was discarded. The sodium acetate 
buffer was added again and the steps were repeated for 2 more cycles. 40 mL of 0.2-0.3 M 
cobalt solution (CoCl2·6H2O) was added to the resin and the resin was left to mix on a bench 
rotator for overnight.  
 The cobalt-charged resin suspension was centrifuged at 4000 x g for 5 minutes and 
the supernatant was discarded. 40 mL of sodium acetate buffer was added to the resin, mixed 
thoroughly then centrifuged at 4000 x g for 5 minutes. This step was repeated two more 
times, followed by 3 similar washes with distilled water and 2 washes with lysis buffer. 40 
mL of lysis buffer was then added and the resin was left to mix overnight on a rotator placed 
inside a 4°C environment.  
2.4.5. Purification of OSBP 
 A frozen pellet (~5 mL volume, ~2 g mass of wet cells) of Sf21 cells was taken out 
and left to thaw on ice. 20 mL of lysis buffer and 1 tablet of protease inhibitor (complete 
Tablets Mini EDTA-free EASYpack) were added to the pellet. Using a pipette, the pellet and 
the tablet were thoroughly broken in the lysis buffer. The mixture sat on ice for a 30 minute 
incubation period. The lysed cells were further broken by passing them through 18 gauge 
and 23 gauge needles for a minimum of 5 times. The lysed cells were then sonicated using 
a probe sonicator (QSonica Sonicators) for 1 minute set to 5 sec/pulse. 5-10 µL of DNase 
(10,000 units) was then added and the mixture sat on ice for another 30 minute incubation 
period.  
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 The lysed cells were then transferred to a SS-34 Sorvall tube and centrifuged at 
40,000 x g for 45 minutes using the Thermo Scientific Sorvall Centrifuge – SS-34 Rotor. In 
the meantime, the resin-lysis buffer mixture was split into two 50 mL Falcon tubes and spun 
for 5 minutes at 4,000 x g. The supernatant of the resin was discarded, and the supernatant 
of the cells was added to the resin. The resin-lysed cells mixture was left to thoroughly mix 
on a rotator overnight in a 4°C environment.  
 The incubated resin was transferred to a Bio-Rad glass column. Using gravity, the 
resin mixture was passed through the column enabling the resin to settle with a minimal 
layer of liquid on top. The glass column was then set up on its holding apparatus and 
transferred to a fast protein liquid chromatography (FPLC) machine (Bio-Rad BioLogic 
DuoFlow) for an automated purification procedure.  
 Prior to purification, the FPLC (Bio-Rad BioLogic DuoFlow) was washed using 
ethanol, water and purification wash buffer (Buffer A). The column was then set up on the 
FPLC machine and the automated purification protocol was started. The FPLC was set to 
pass 40 mL of purification wash buffer (100% Buffer A) at 4 mL/min, followed by 40 mL 
of low imidazole (20 mM) wash buffer (92% Buffer A, 8% Buffer B) at 4 mL/min and 40 
mL of high imidazole (200 mM) wash (elution) buffer (20% Buffer A, 80% Buffer B) at 4 
mL/min. Flow-through of the low and high imidazole washes were collected for analysis. 
The FPLC machine was set to monitor protein elution at UV/Vis absorbance of 280 nm. 
During the initial stages of the high imidazole wash, a small peak in absorbance was 
observed indicating the presence of the protein. The column was then washed using MES 
buffer before removal from the FLPC and storage.  
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 After the purification of OSBP was complete, the resin was subjected to the removal 
of its metal ions using sodium phosphate buffer (Cleaning buffer 2), cleaning using acetic 
acid/phosphoric acid buffer (Cleaning buffer 1) with an exposure of 10 – 15 minutes, and 
recharged as per previously discussed.  
2.4.6. Protein Quantification 
 Quantification of protein was performed using the Bradford assay method and the 
Bradford reagent (BioShops). Bovine serum albumin (BSA), concentrations from 10 µg/mL 
to 1000 µg/mL were prepared in 50 µL total volume in PBS buffer and added to 1 mL 
Bradford reagent in 1.5 mL plastic cuvettes. The absorbance of the samples were measured 
at 595 nm and through interpretation, a linear regression model of the standard curve was 
determined. 50 µL of potential protein sample was added to 1 mL Bradford reagent in 1.5 
mL cuvette had its absorbance measured at 595 nm. Using the absorbance value and 
equation of the regression line analysis, the protein concentration was calculated.   
2.4.7. SDS-PAGE Electrophoresis   
 Samples collected including supernatant, washes and protein were analyzed for 
purity using SDS-PAGE. The SDS-PAGE gels were commercially supplied or self-made 
using recipes shown in Table 1.  
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Table 1: SDS-PAGE gel recipe of 12% separating gel and 4% stacking gel for 6 gels. 
 12% Separating Gel 4% Stacking Gel 
Distilled Water 20.5 mL 18.8 mL 
Stacking Buffer - 7.5 mL 
Separating Buffer 12.0 mL - 
40% Acrylamide/Bis-
Acrylamide 
14.4 mL 3.0 mL 
10% SDS 480 µL 300 µL 
50% Glycerol 100 µL 74 µL 
TEMED* 48 µL 30 µL 
10% APS* 480 µL 300 µL 
*TEMED and APS were added at the end, right before pouring into apparatus.  
 The Mini-PROTEAN III (Bio-Rad) gel castings were assembled according to 
manufacturer’s instructions. The 12% separating gel formula was poured into the gel 
castings and left to polymerize for 30 minutes to 1 hour with an overlaid layer of iso-
propanol. After polymerization, the iso-propanol was poured out and completely removed 
using a kim-wipe. The stacking gel formula was then poured on top of the stacking gel, 
followed by the addition of the comb and left to polymerize for a minimum of 30 minutes. 
The gel was then covered with paper towels hydrated with distilled water and stored at 4°C 
overnight.  
 Prior to SDS-PAGE, the comb of the gel was removed and the gel castings were set 
up on the Bio-Rad SDS-PAGE apparatus. SDS-PAGE buffer was poured in the middle of 
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the apparatus to let the bubbles escape. Up to 25 µL of to-be-analyzed samples (~2 µg of 
protein) were each mixed with up to 5 µL of 6x SDS-PAGE loading buffer and denatured 
in a water bath set to 95°C for 5 minutes. Each sample was loaded into a separate well, and 
alongside the protein samples, 8 µL of commercially supplied pre-stained broad range 
protein marker was loaded. The gel was then ran at 120 V for 1.75 hours.  
 Prior to analysis, the protein gel was stained for a minimal of 6 hours in a staining 
solution (10% ProtoBlue and 90% EtOH), followed by destaining with distilled water for 
overnight. During the use of the commercially supplied stain-free gels (BioRad), the staining 
protocol was exempted. Using the Bio-Rad Gel Doc Ez Imager, a gel picture was obtained 
under white light and then was analyzed using Bio-Rad Image Lab software.  
2.4.8. Buffer Exchange  
 The commercially supplied buffer exchange column was set up, and exchange buffer 
in the column was left to drain out. 10 mL of the buffer of interest (commonly DPI buffer) 
was added and left to flow through. 3 mL of protein sample was added and left to flow 
through. 4 mL of the buffer of interest (commonly DPI buffer) was added and collected in 
5 mL culture tubes. The addition of protein sample and buffer of interest steps were repeated 
until all the protein samples have passed through. The column was then washed with a 
minimal of 10 mL of PBS buffer. The column was then filled back up with PBS buffer + 
minimal sodium azide mixture (0.02%) before storing on bench top. Upon the completion 
of buffer exchange, the protein samples are concentrated using Amicon Ultra Centrifugal 
Filters Ultracel – 50K (spun at 4000 x g using Beckman Coulter Allegra X-30R Centrifuge 
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– SX4400 rotor for 8 minutes) and re-quantified using Bradford assay as previously 
discussed.  
2.4.9. Ion-Exchange Chromatography 
 3 mL of commercially supplied DEAE Sepharose resin (Bio-Rad Macro-Prep DEAE 
Support Weak Anion Exchange Support) was prepared as per company protocol (removed 
storage buffer, equilibrated in running buffer, added protein, set up column apparatus and 
transferred to FPLC machine (Bio-Rad BioLogic DuoFlow) for an automated protocol). 50 
mL of low salt wash buffer (90% running buffer (RB), 10% salt buffer (SB)) was then passed 
through followed by 20 mL of medium salt wash buffer (50% RB, 50% SB) and then 30 mL 
of high salt wash buffer (100% SB). The flow rate was set to 1 mL/min and all eluted 
samples of 3 mL aliquots were collected and analyzed for purity.  
2.4.10. Unilamellar Vesicle Preparation  
2.4.10.1. Large Unilamellar Vesicle Preparation (DPI Lipids) 
 Lipids (Avanti Polar Lipids) were aliquoted to appropriate compositions in glass 
vials. The total volume of the lipids was prepared in sets of 2 mL and was based on the test 
the lipids were to be used for; e.g. DPI lipid binding assay. The chloroform solvent of the 
lipid compositions was evaporated using nitrogen gas, followed by a mechanical vacuum 
pump for 45 minutes to 1 hour. The lipids were then hydrated with the appropriate amount 
of buffer appropriate for the test the lipids were to be used for (e.g. DPI buffer for DPI lipid-
binding assay). The hydrated lipids were lightly vortexed, then left overnight in a 4°C 
environment.  
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 Prior to their use, the lipids were lightly vortexed again and were extruded using 
Avanti Polar Lipids extrusion apparatus/Hamilton Gastight #1001 using 100 nm filters 
(Avestin Polycarbonate Membrane – 100 nm). The lipids were passed through the filter 15 
times. Extruded lipids were used immediately or within 24 hours of their extrusion.  
2.4.11. Dual Polarization Interferometry – Membrane Lipid-Protein Binding Assay 
 The DPI machine (Farfield AnaLight Bio 200) protocol was a modification to the 
protocol provided by Farfield Scientific Ltd. After the machine (Farfield AnaLight Bio 200) 
and pump (Harvard Apparatus PHD 2000 Programmable Pump) were turned on and the 
lamp was left to warm up, air was injected into the machine multiple times ensuring minimal 
amount of liquid remained in the tubes of the machine. The chip holder was then taken out, 
and the chip (AnaLight Bio 200 FB80) and its silicon cover were then cleaned using 2% 
Hellmanex, 10% SDS, 50% isopropanol (IPA), 80% EtOH and finally distilled water. In 
cases of difficult to handle chips (difficult to obtain clean fringes), distilled acetone was used 
as well. The chip holder was set back into the machine and DPI buffer was flowed through 
the machine using the external pump set to 100-250 µl/min. 0.8 mL of 50% IPA was then 
injected and flowed through using the pump setting of 100 µl/min. It is important to note 
that every injection performed was done with a minimal volume of 0.7 mL in which a total 
of 200 µL is passed through each channel. In addition, the flow rate was controlled via the 
external pump (Harvard Apparatus PHD 2000 Programmable Pump), and the injection was 
commanded via the DPI injection software (AnaLight Explorer Inject software) on the 
connected computer. The DPI machine software (AnaLight Bio 200) was then opened, and 
the channels of the chip were examined for the best possible selection of fringes, a section 
within an observational window of the interference pattern that was produced from the light 
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shining through the sensing waveguide and reference waveguide. Upon successful selection 
of fringes, the machine was considered ready for protein-lipid binding assays.  
 Protein-lipid binding assays began after calibration of DPI machine (Farfield 
AnaLight Bio 200) using EtOH and distilled water. Leaving the window open (DPI injection 
software [AnaLight Explorer Inject software] program set to 1 µL/min), 80% EtOH was 
injected at flow rate of 100 µL/min (pump flow rate) for exactly 1 minute and 30 seconds 
then changed to a 15 µL/min flow rate (pump flow rate). The real-time examined signal 
dropped, after a sharp increase, to a flat line as the EtOH was completely passed through the 
channels. The injection channel window was then reset and all subsequent injections were 
made to a program injection flow rate equal to the pump (Harvard Apparatus PHD 2000 
Programmable Pump) flow rate. Distilled water was then injected at a flow rate of 50 µL/min 
and the calibration process was completed.  
 Protein-lipid DPI binding assays began with an injection of the lipid of interest (e.g. 
0.5 mM 100% DOPC) at a flow rate of 25 µL/min followed by a DPI buffer injection set at 
50 µL/min. The protein of interest (e.g. 1.0 µM of wt-OSBP) was then injected at a flow 
rate of 25 µL/min. The protein injection was monitored beyond its injection period up until 
no change in signal can be observed. The chip was then cleaned and reset for another protein-
lipid binding test using injections of 2% Hellmanex, 10% SDS, 50% IPA, 80% EtOH, 
distilled water and DPI buffer set to a flow rate of 50 µL/min or 100 µL/min.  
 Data produced via the DPI machine software was saved and analyzed through the 
DPI analysis software (AnaLight Explorer software) using the protocol provided by Farfield 
Scientific Inc.  
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2.4.12. Fluorescent Based Assays 
2.4.12.1. Binding Assay 
 The Photon Technology International (PTI) fluorometer was turned on and the xenon 
lamp was ignited and left to warm up to a setting of ~140 W. Test samples were made to a 
composition of 0.2 µM protein of interest (e.g. wt-OSBP) and DPI buffer to a total volume 
of 1 mL in quartz cuvettes. The fluorometer was set with a slit width of 6 nm, and an 
emission and excitation wavelengths based on the fluorescent ligand of interest (e.g. 
excitation of 469 nm and emission of 537 nm for 22-NBD-cholesterol). The window in 
which the fluorescence of the ligand was monitored was set to the suggested minimal ± 10 
nm of the emission wavelength (e.g. 527-547 nm in the case of 22-NBD-cholesterol). A 
background fluorescence value was obtained for each of the samples prior to the addition of 
fluorescent ligand. Volume of 0.5-1.0 µL of fluorescent ligand (e.g. 22-NBD-cholesterol) 
from different stocks was added to each sample. The samples were then incubated for 8 
minutes while mixing end over end using a bench top rotator. Each sample was subsequently 
measured and the fluorescent values were recorded.  
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3. RESULTS AND DISCUSSION 
3.1. Growth of Sf21 Cells  
 Prior to the start of this thesis, the Sf21 cells were grown using a similar protocol to 
the one previously outlined (section 2.4.1) with the exception of T-75 flasks instead of T-25 
and different volumes. The previous protocol was initiated by my colleague Parthajit 
Mukherjee, in which the total flask volume was 20 mL (1 mL of initial stock of cells, 19 mL 
of culture medium). Instead of the 0.5/0.5/1 mL volumes in the T-25 protocol, the volumes 
were 1/1/3 mL. For the suspension culture, instead of the initial 1 mL to 24 mL of medium, 
3 mL to 47 mL of medium was used instead. The cell growth pattern, cell density, remained 
quite similar for both protocols and prior to subculture, the monolayer cultures had an 
average cell density between 2 ×106 cells/mL and 8 ×106 cells/mL with an average cell 
viability between 95-99%. The protocol was adjusted to use T-25 flasks instead of T-75 
flasks in order to save cost on material and medium. The growth of the cells was monitored 
and observed under a microscope. Figure 14 displays Sf21 monolayer culture at different 
magnifications after sub-culturing (Day 0). Figure 15 displays Sf21 monolayer culture after 
2 days of growth with different magnifications. Figure 16 displays Sf21 monolayer culture 
at different magnifications prior to being sub-cultured (Day 4).  
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Figure 14: Sf21 monolayer culture after sub-culturing (Day 0) under different 
magnifications (10×, 20× and 40× respectively). The red lines in the bottom corners 
represent 5 µm, 2 µm and 2 µm for each magnification respectively. The cells at this stage 
are not confluent.  
 
Figure 15: Sf21 monolayer culture after 2 days of growth under different magnifications 
(10×, 20× and 40× respectively). The red lines in the bottom corners represent 5 µm, 2 µm 
and 2 µm for each magnification respectively. The cells at this stage are becoming more 
confluent, however they are not ready to be sub-cultured just yet.  
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Figure 16: Sf21 monolayer culture prior to being sub-cultured (Day 4) under different 
magnifications (10×, 20× and 40× respectively). The red lines in the bottom corners 
represent 5 µm, 2 µm and 2 µm for each magnification respectively. The cells at this stage 
have become confluent and are ready to be sub-cultured.  
Due to the figures being in black and white, it is hard to visualize the viability of the 
cells in the previous cell culture. However, Figures 14-16 do display the growth of cells and 
Figure 16 displayed the cells being around 90% confluent. Taking Figure 16 into 
consideration, the Sf21 suspension culture on day 4 could be used as a comparison (Figure 
17).  
 
Figure 17: Sf21 suspension culture under different magnifications (10x, 20x and 40x 
respectively) prior to being sub-cultured (Day 4). The red lines in the bottom corners 
represent 5 µm, 2 µm and 2 µm for each magnification respectively. The cells have not 
ruptured and are circular in shape.  
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 It is important to note that the shape of the Sf21 cells remained circular. 
Unhealthy/dead cells would show abnormal shapes including ruptured spheres similar to 
that of bloated infected cells (see section 3.2).  
 The current protocol for the growth of Sf21 suspension cell cultures incorporated the 
use of the New Brunswick Scientific Co. Incubator Shaker Series 25, a shaker incubator in 
E-Block (E-303). Prior to the use of this shaker incubator, the cell cultures were grown in 
New Brunswick Scientific Co. Incubator Shaker Series I26, a shaker incubator in the Cairns 
laboratory. However, unexpected and unknown contamination of small sphere like cultures 
occurred frequently.  
 While troubleshooting the contamination, the possibility of poor handling or lack of 
appropriate sterile technique was first suspected. After new stringent handling rules were 
set, the unknown contamination occurred again. The machines (shaker incubator and 
biological safety cabinet) and equipment handled were then suspected and were thoroughly 
surface disinfected using 100% bleach and a stronger disinfectant, Vikron. Despite this, the 
contamination occurred again at random stages of cell growth. Different surfaces of the 
laboratory environment were tested for contamination using a cotton swab test, in which 
cotton swabs were rubbed on different suspected surfaces (gloves, lab coats, biosafety 
cabinet, shaker incubator, etc.) and placed in 15 mL Falcon tubes holding 5 mL of culture 
medium. The cotton swap cultures were placed inside the bench top incubator set at 28˚C. 
The cotton swab cultures showed negative results (i.e. no growth) except for the control, 
which was the cotton swab that was wiped with the contaminated suspension culture. 
Commercially supplied culture medium was also suspected and each time a culture showed 
evidence of contamination the culture medium was discarded and a new bottle was prepared. 
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Prior to the use of the new medium, the culture medium, FBS, pen-strep and fungizone were 
passed through a 0.45 micron filter in a sterile environment. However, this did not stop the 
occurrence of contaminated cultures. Antibiotics and fungizone concentrations were tripled 
to combat the contamination, but with no success.  
Culture contamination became a great challenge for this research project as the 
contamination remained a mystery in both its frequency and identity. The greatest challenge 
was in the early identification of this contamination as it always occurred unexpectedly. 
Promisingly, early detection of contamination was possible by frequent physical 
examination of the cultures. During the handling of contaminated suspension cultures, a 
sweet smell was present. In addition, contaminated suspension cultures appear to be bright 
in color showing a white-yellow rather than the light yellow almost transparent color in 
healthy cells. Furthermore, a ring of cells at the air-water interface was observed in the 
suspension cultures. The further along the contamination was, the more distinct the layer 
became. Whenever a contamination was suspected, the culture was discarded according to 
the appropriate safety guidelines and a new culture was set up.  
During one of the last few occurrences of contamination, the contaminated cell 
culture was plated on LB agar plates by Dr. Alan Castle and observed. His observation 
indicated the presence of a cocktail that included Aspergillus sp. and bacteria. At this stage 
and with the help of a colleague at Brock University, Dr. Mark Lukewich, new cultures were 
set up using different biosafety cabinet and grown in different incubators (New Brunswick 
Scientific Co. Incubator Shaker Series 25). With this change in environment, the frequency 
of contamination decreased drastically. 
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Monolayer cell cultures showed consistent healthy pattern of growth for 20-30 
generations. When the growth pattern slowed, cell cultures were left to grow for another 
day, or a higher volume of cells was seeded or they were discarded and a new frozen stock 
culture was used. Suspension cultured cells that were not used for infection were seeded for 
the next suspension sub-culture. Healthy suspension cultures were able to be sub-cultured 
for 5-10 generations. Similarly, if suspension cultures showed a slower growth pattern, they 
were left to grow for another day, or a larger volume of cells was seeded, or the culture was 
discarded and a new suspension culture begun from a monolayer culture.  
3.2. Baculovirus Infection of Sf21 Cells (Expression of OSBP and Baculovirus)  
 When healthy suspension cultures were obtained, 4.5 × 108 cells were isolated and 
set for infection. Initial stocks of baculovirus were provided by Dr. Neale Ridgway 
(Dalhousie University, Halifax) with pre-calculated titre values. A titre of 0.15 was found 
to be optimal for OSBP expression in combination with an infection incubation period of 72 
hours. Successful trials of infections yielded protein and a subsequent generation of 
baculovirus. Baculovirus was located in the supernatant of the cell pellet that was made upon 
the completion of the infection. The collected supernatant was passed through a 0.22 micron 
filter and a plaque assay was performed in order to calculate its viral yields. Unfortunately, 
in several failed plaque assays attempts, the titre values of collected baculovirus could not 
be determined. Subsequent infections incorporated an estimated volume of baculovirus (0.5 
mL – 2 mL) to be added and after multiple successful trials based of protein expression, the 
optimal value was determined to be 1 mL. Upon the completion of the infection stage, the 
cells were observed under a microscope and were typically larger in size (Figures 18-19). 
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For the best expression of OSBP, the Sf21 infected cells had increased significantly in size 
in shape yet were not ruptured.  
 
Figure 18: Day 3 (72 hours) of Sf21 suspension culture infected with OSBP-S5E baculovirus 
provided by Dr. Neale Ridgway under different magnifications (10x, 20x and 40x 
respectively). The red lines in the bottom corners represent 5 µm, 2 µm and 2 µm for each 
magnification respectively. Upon a complete infection, the cells have increased in size to 
1.5 – 2 times bigger in diameter.   
 
Figure 19: Day 3 (72 hours) of Sf21 suspension culture infected with OSBP-S5E baculovirus 
obtained from the filtered supernatant of a pre-infected culture under different 
magnifications (10x, 20x and 40x respectively). The red lines in the bottom corners 
represent 5 µm, 2 µm and 2 µm for each magnification respectively. Upon a complete 
infection, the cells have increased in size to 1.5 – 2 times bigger in diameter.  Few of the 
cells have ruptured and lost their circular shape.  
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 The best method to define the success of the infection (i.e. expression of OSBP) was 
to examine the infected cells under a microscope prior to pelleting. Too many ruptured cells 
would indicate that the infected cells were left for too long or too much baculovirus was 
added. Too little or no bloated cells would indicate very little to no infection and thus poor 
expression of OSBP. This indicated that too little baculovirus was used, or the baculovirus 
stock was too old (usually after 8 months of storage) and became inefficient. Alternatively, 
the infection period was too short and a 96-hour incubation period should be considered. 
Cultures of potentially successful expression of OSBP were pelleted and stored at -80˚C.  
3.3. Purification of OSBP  
 While a successful expression of OSBP could be judged through an observation of 
the cells prior to their centrifugation (see section 3.2), this method was at times inaccurate. 
Occasionally, what appeared to be successfully infected cells resulted in a very low or no 
yield of protein. The success of an OSBP expression could only be determined after the 
purification process was done. 
 The initial protocol for the purification process started with mixing one OSBP pellet 
(~5 mL volume, ~2 g mass of wet cells) representing cells collected from 250 mL of infected 
cell culture with 5 mL of metal-affinity resin. However, the expression of OSBP-S5E protein 
was relatively low (about half the amount) in comparison to wt-OSBP (estimates of protein 
yield can be found in section 3.4 – table 2). Given the low expression of desired protein, 
other proteins were often found non-specifically bound to the resin during the purification 
process (Figure 22). This could be mostly avoided by combining two pellets for 5 mL of 
resin, which yielded higher purity of the recovered protein.  
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 During the purification process, the FPLC program (Bio-Rad BioLogic DuoFlow) 
measured the absorbance values of the eluted sample in real time. Looking at Figures 20 and 
21, which highlight regions in which the washes and elution of protein were observed at 280 
nm. The absorbance at 280 nm starts at a high value (~2.5) when the unbound protein 
fraction was passing through the column as the first wash was applied (0-20 min). The 
second region (20-30 min) was when the low imidazole buffer wash was passing through 
the column, while the third region (30-40 min) was when the high imidazole elution buffer 
was passing through the column. The presence of protein can be observed through a small 
yet significant increase (hump like shape) as seen in a good case of expression (Figure 21).  
 
Figure 20: Absorbance at 280 nm, conductivity (mS/cm) and change in buffer B of the 
sample that passed through IMAC column during very low expression of S5E (1 pellet of 
OSBP-S5E with 5 mL of resin). The distinct protein peak was absent.  
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Figure 21: Absorbance at 280 nm, conductivity (mS/cm) and change in buffer B of the 
sample that passed through IMAC column during a good expression of S5E (2 pellet of 
OSBP-S5E with 5 mL of resin). The distinct protein peak was present.  
 A similar purification to that of Figure 21 was analyzed under SDS-PAGE with the 
resulting gel picture of Figure 22. The presence of the peak in fractions 35-36 with the 
corresponding analysis under SDS-PAGE confirms the presence of OSBP-S5E. The size of 
the OSBP-S5E protein bands was approximately ~90 kDa which is similar to that reported 
by Goto, et al. (27).  
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Figure 22: SDS-PAGE of OSBP-S5E purification by cobalt affinity column through an 
automated process using the FPLC machine Bio-Rad BioLogic DuoFlow; where PM is the 
protein marker (New England BioLabs), CL is the cell lysate, FT is the flow-through, F# is 
the fraction number, wash 1 is the first wash with no imidazole, wash 2 is the second wash 
with 20 mM imidazole, and eluted fractions is the purified protein eluted using 200 mM 
imidazole. OSBP-S5E was prominent in fractions 35 and 36.  
3.4. OSBP Quantification  
 Purified fractions of OSBP were quantified by Bradford assay. Bradford reagent 
(Sigma-Aldrich), and 50 µL of a purified sample were mixed and the absorbance measured 
at 595 nm. The concentration of the protein was calculated based on the regression analysis 
of the linear portion of the curve. Known concentrations of bovine serum albumin (BSA) 
were used and a calibration curve was constructed yielding an equation of y=1.0275x, in 
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which y is the absorbance at 595 nm and x is concentration of protein sample in mg/mL 
(Figure 23). 
 
Figure 23: Bradford assay calibration curve constructed using known concentrations of BSA 
and absorbance at 595 nm (courtesy of Parthajit Mukherjee).  
 The amount of purified OSBP-S5E for a few of the attempts made are reported in 
Table 2. These values were measured after the buffer exchange was done (from imidazole 
elution buffer to DPI buffer) and the protein was concentrated using Amicon Ultra 
Centrifugal Filters Ultracel – 50K. On average, approximately 0.4 mg of protein was eluted 
per purification process of 2 pellets at a time.  
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Table 2: Recovery of OSBP-S5E. The amount of purified OSBP-S5E per 2 pellets per 
purification and their corresponding dates determined using the Bradford assay. Reported 
are absorbance at 595 nm (A595), the concentration of OSBP-S5E in mg/mL and µM, the 
volume of purified fractions in mL and the mass of purified OSBP-S5E in mg. 
Attempt Corresponding 
Date 
A595 [OSBP-
S5E] 
(mg/mL) 
[OSBP-
S5E] 
(µM) 
Volume 
of 
Fraction 
(mL) 
Mass of 
OSBP-
S5E (mg) 
1 Mar 19/2015 0.176 0.171 1.90 3.87 0.663 
2 Mar 19/2015 0.069 0.067 0.75 3.87 0.260 
3 Jul 28/2015 0.198 0.193 2.14 2.10 0.405 
4 Nov 3/2015 0.128 0.125 1.38 1.18 0.145 
Average  0.143 0.139 1.54 2.76 0.369 
 
3.5. Ion-Exchange Chromatography 
 During the first attempted purification of OSBP-S5E, multiple contaminating bands 
(~30-45, 60 kDa) with less intensity than the 90 kDa OSBP protein were observed in the 
purified fractions. With the hope of further purifying OSBP-S5E, ion exchange 
chromatography was attempted. Using DEAE Sepharose resin (Bio-Rad Macro-Prep DEAE 
Support Weak Anion Exchange Support), the column was prepared as described in section 
2.4.9. The resin (3 mL) was centrifuged at 4000 x g using a Beckman Coulter Allegra X-
30R Centrifuge SX4400 rotor for 5 minutes and the storage buffer was discarded. The resin 
51 | P a g e  
 
was then washed twice with distilled water, followed by another two washes using the 
running buffer (RB – 50 mM Tris, pH 8.5) and equilibrated with the running buffer 
overnight. The resin was then transferred to a Bio-Rad glass column (similar to that used in 
purification of protein) and the resin was left to settle by gravity. The purified S5E protein 
fractions were then loaded onto the column and the column apparatus was setup and 
transferred to the FPLC machine (Bio-Rad BioLogic DuoFlow) for an automated protocol. 
OSBP-S5E was exposed to the combination of a running buffer (RB) and a salt buffer (SB) 
in order to create three different concentrations of salt (20 mM, 250 mM and 500 mM NaCl). 
50 mL of a low salt wash (90% running buffer (RB), 10% salt buffer (SB)) was passed 
through the column first in order to wash any non-specific binders. The concentration of salt 
was then increased to 250 mM and 20 mL of a medium salt wash (50% RB, 50% SB) was 
then passed through the column as to elute the OSBP-S5E protein. The concentration of salt 
was increased again to 500 mM NaCl and 30 mL of a high salt wash (100% SB) was passed 
through the column as to ensure no protein was still bound to the column.  
The flow rate was set to 1 mL/min and all eluted samples were collected and 
analyzed for purity. The purification process was automated through the FPLC machine in 
which the sample passing through the column was monitored by the change in absorbance 
at 280 nm and the change in conductivity. 
 Variability in the monitored absorbance and conductivity during the purification 
process was observed in which multiple sudden changes in absorbance and conductivity 
occurred. This was due to the input versus output flow rate of the column. Although the 
FPLC machine was set to flow at rate of 1 mL/min, it was only the sample input (into the 
column) flow rate that was consistent with the FPLC machine setting. The output (leaving 
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the column) flow rate could not be controlled by the FPLC machine and was drastically 
affected by the resin and the packing of the column. Although the resin was packed by just 
using gravity, the resin did slow the output flow rate resulting in a backlog of wash buffer, 
which collected on top of the resin. The resulting backlog of wash buffer changed the 
concentration of the salt that was passing through the resin. In other words, without the 
backlog of the buffer, each drop of wash buffer entering the column would almost directly 
touch the resin and, for example, at the start of the medium salt wash, the change in salt 
concentration changes immediately from 20 mM to 250 mM. However, when the 
backlogged buffer is present, the salt concentration does not directly change from 20 mM to 
250 mM; but rather changes from 20 mM to 250 mM gradually. This results in the OSBP-
S5E being eluted in a diluted fashion and over multiple fractions. At times like this, the input 
flow rate was decreased to 0.1 mL/min to allow the backlogged buffer to pass through the 
resin. It was necessary at times to pause the protocol (i.e. input flow rate of 0 mL/min) or 
take apart the column in order to allow the backlogged buffer to pass through. This was a 
challenge as the output flow rate did decrease after a short period of time from changing the 
input flow rate. After multiple adjustments, the best flow rate that gave the most stable 
input/output flow rate was 0.35 mL/min.  
 SDS-PAGE was performed on samples from the collected fractions of the ion 
exchange chromatography (Figure 24). The SDS-PAGE gel (Figure 24) showed that there 
was little to no change in the purity of the protein samples that had passed through the ion 
exchange chromatography. 
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Figure 24: SDS-PAGE of OSBP-S5E purification by ion exchange chromatography (using 
Bio-Rad Macro-Prep DEAE Support Weak Anion Exchange Support) through an automated 
process using the FPLC machine (Bio-Rad BioLogic DuoFlow). This purification was done 
after the OSBP-S5E was purified by a cobalt affinity column. The ‘Before IEC’ gel was 
adapted from Figure 22. PM is the protein marker (New England BioLabs), F# is the fraction 
number, and eluted fractions are the purified protein. OSBP-S5E was prominent in fractions 
35 and 36 before IEC and fractions 24 to 27 after IEC. Please note that the samples used for 
the IEC were not the same samples as the ‘Before IEC’ samples. However all samples were 
of OSBP-S5E but of two different purifications.  
 Due to the multiple challenges that arose during the first attempt of OSBP-S5E ion 
exchange chromatography, another attempt was made to a newly purified protein. However, 
the ion exchange chromatography showed no improvement in the purity of OSBP-S5E 
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protein. This was in accordance with an attempt previously made by Parthajit Mukherjee 
with wt-OSBP in which the result was the same.  
3.6. DPI – Membrane Lipid-Protein Binding Assay  
  The behavior of the binding kinetics of OSBP to different compositions of lipid 
bilayers was examined by dual polarization interferometry. Lipid vesicles (~100 nm in size, 
0.5 mM) extruded using 100 nm polycarbonate membrane filters were injected into the DPI 
machine using a programmable pump and across the sensor chip.  During contact with the 
chip the vesicles adsorbed and flattened forming a single bilayer on top of the silicon 
oxynitride chip (42). The adsorption of 1.0 µM of OSBP to lipids of varying composition 
was analyzed at a flow rate of 25 µl/min over the period of ~600 s. Controls were previously 
done by Parthajit Mukherjee and other colleagues to determine which concentrations of 
lipids and protein to use at this flow rate and observation time window.  
 The work that was done with α-tocopherol transfer protein (α-TTP) in our laboratory 
using dual polarization interferometry set the ground rules in the interpretation of the DPI 
results (43; 44; 45). Baptist et al. have demonstrated that α-TTP, which binds well to 
bilayers, formed an adsorbed protein mass of ~0.75 ng/mm2 when 1.0 µM of α-TTP was 
exposed to an immobilized bilayer of 9:1 DOPC:DOPS (45). Values of adsorbed protein 
mass lower than that can be viewed as a relatively poor membrane binding protein.  
 The binding of OSBP to DOPC lipid membranes showed only a small change in 
specific binding mass (represented by protein binding to the immobilized bilayer) for both 
wt-OSBP and OSBP-S5E (Figure 25). The binding of both wt-OSBP and OSBP-S5E to an 
immobilized DOPC bilayer formed an adsorbed protein mass of ~0.5 ng/mm2 (Figure 26); 
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making OSBP, regardless of its phosphorylation state, a somewhat poor binder to neutral 
PC bilayers.  
 Upon injection of the protein sample, the adsorbed protein mass rapidly increases 
reflecting a temporary formation of layer that quickly dissociates once the injection has 
ended (indicated by arrow) (Figure 25). This does not necessarily represent the binding of 
protein to the immobilized lipid bilayer, but rather could be the protein floating on top or 
near the lipid bilayer that caused the change in signal. This behavior in combination with a 
low (≤ ~0.5 ng/mm2) adsorbed protein mass value can be interpreted as a relatively poor 
binding protein to that lipid composition; such was the case in wt-OSBP and OSBP-S5E on 
DOPC bilayers (Figure 26). In addition, layers lower than ~0.3 ng/mm2 are considered 
unreliable and were not taken in consideration.  
T im e  (s )
S
p
e
c
if
ic
 M
a
s
s
 (
n
g
/m
m
2
)
0 1 0 0 2 0 0 3 0 0 4 0 0 5 0 0 6 0 0
0 .0
0 .2
0 .4
0 .6
0 .8
1 .0
w tO S B P
O S B P -S 5 E
 
Figure 25: Real time association of 1.0 µM of wt-OSBP and OSBP-S5E with DOPC neutral 
bilayer. The adsorbed protein mass quickly increased at the beginning of the injection of 
protein and quickly decreased at the end of the injection. The behavior of wt-OSBP with 
DOPC bilayer was similar to that of OSBP-S5E.  
End of Injection 
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Figure 26: Maximum adsorbed mass of 1.0 µM wt-OSBP and OSBP-S5E to an immobilized 
neutral DOPC bilayer (courtesy of Parthajit Mukherjee). Regardless of phosphorylation 
state, OSBP adsorbed to an approximate 0.5 ng/mm2 adsorbed mass of protein. Both samples 
were run in duplicates.   
The binding of wt-OSBP and OSBP-S5E to PI(4)P containing lipid membranes are 
different (Figure 27-28). The behavior of wt-OSBP on 2% PI(4)P containing lipid 
membranes showed a gradual increase in adsorbed mass, followed by a slower gradual 
decrease over time before the end of injection (Figure 27). For OSBP-S5E, such behavior 
was absent and instead a rapid increase at the start of the flow of protein and a rapid decrease 
at the end of the flow of protein were observed (Figure 28). Wt-OSBP adsorbed with high 
affinity to PI(4)P containing bilayers and the adsorbed mass of wt-OSBP increased with 
increasing percentages of PI(4)P (Figure 27). The slow desorption of wt-OSBP from PI(4)P 
containing membrane may indicate that wt-OSBP was first adsorbing then extracting PI(4)P 
from the lipid bilayer. As the bilayer is depleted of PI(4)P lipids, the affinity of wt-OSBP 
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for the bilayer membrane then returns to that for a DOPC bilayer (Figure 25). The absence 
of such behavior (the quick increase followed by gradual decrease in adsorbed protein mass) 
in OSBP-S5E (Figure 28) may indicate that the phosphorylation of those 5 serine residues 
(S5E) prevents lipid recognition and/or PI(4)P extraction. Additional tests, such as mass 
spectrometry, which could identify PI(4)P through its mass peak, on collected fractions 
and/or antibody detection methods for PI(4)P, are needed to confirm the extraction process.  
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Figure 27: Real time association of 1.0 µM of wt-OSBP with a DOPC bilayer containing 
varying concentrations of PI(4)P (1-6%). Wt-OSBP adsorbed with high affinity to PI(4)P 
containing bilayers and the adsorbed mass of wt-OSBP increased with increasing 
percentages of PI(4)P. This was followed by a slow desorption of wt-OSBP from PI(4)P 
containing membranes. 
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Figure 28: Real time association of 1.0 µM of OSBP-S5E with DOPC bilayer of varying 
concentrations of PI(4)P (1-6%). OSBP-S5E adsorbed quickly to PI(4)P containing bilayers 
upon injection of protein and quickly desorbed from PI(4)P containing membranes upon the 
completion of the injection. Increased PI(4)P percentages did not significantly change 
specific bound mass of OSBP-S5E to PI(4)P containing bilayers except slightly in the case 
of 6% PI(4)P likely due to protein sticking longer due to excess PI(4)P.   
 In the presence of sterol, the overall binding behavior of OSBP, regardless of 
phosphorylation state, was fairly similar (Figures 29-32). Though the maximum specific 
binding mass of OSBP to cholesterol- versus oxysterol-containing membranes differed, it 
did not differ in terms of varying the concentration of the sterol that was present (Figure 33). 
In other words, regardless of the concentration of sterol that was present, the maximum 
specific binding mass was the same. On the other hand, comparing the behavior of OSBP 
with cholesterol containing membranes and oxysterol containing membranes, it was 
interesting to note that both wt-OSBP and OSBP-S5E showed nearly 2-fold higher 
maximum specific bound mass for cholesterol than that of the oxysterol (25-
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hydroxycholesterol). Interestingly, this was unexpected as literature from Dawson et al. 
showed 25-hydroxycholesterol to have a higher affinity to ORPs than cholesterol does (46; 
47). Although OSBP does adapt its affinity differently to cholesterol than to 25-
hydroxycholesterol, it is still unclear as to why or how that happens.  
With the absence of the wt-OSBP-PI(4)P binding behavior, it can speculated that the 
sterols were not extracted regardless of phosphorylation state. In the case of wt-OSBP and 
PI(4)P containing lipid bilayers, there was a quick and high adsorption of wt-OSBP to PI(4)P 
membranes followed by a slow desorption. In the cases of all other tests, desorption of OSBP 
(rapid desorption) happens only at the end of the injection sample flow, and the absence of 
such desorption behavior (slow desorption) likely indicates the absence of an extraction of 
a ligand. This was the behavior of OSBP (regardless of its phosphorylation state) in the 
presence of varying concentrations of cholesterol and oxysterol. The association of OSBP 
with helper proteins such as VAP-A likely indicates that OSBP, regardless of its 
phosphorylation state, cannot extract sterols without the presence of helper proteins such as 
VAP-A (48). 
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Figure 29: Real time association of 1.0 µM of wt-OSBP with DOPC bilayer of varying 
concentrations of cholesterol (2-20%). Wt-OSBP adsorbed quickly to cholesterol containing 
bilayers upon injection of protein and quickly desorbed from cholesterol containing 
membranes upon the completion of the injection. Increased cholesterol percentages did not 
change specific bound mass of wt-OSBP to cholesterol containing bilayers. 
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Figure 30: Real time association of 1.0 µM of OSBP-S5E with DOPC bilayer of varying 
concentrations of cholesterol (2-20%). OSBP-S5E adsorbed quickly to cholesterol 
containing bilayers upon injection of protein and quickly desorbed from cholesterol 
containing membranes upon the completion of the injection. Increased cholesterol 
percentages did not change specific bound mass of OSBP-S5E to cholesterol containing 
bilayers. 
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Figure 31: Real time association of 1.0 µM of wt-OSBP with DOPC bilayer of varying 
concentrations of 25-hydroxycholesterol (2-20%). Wt-OSBP adsorbed quickly to 25-
hydroxycholesterol containing bilayers upon injection of protein and quickly desorbed from 
25-hydroxycholesterol containing membranes upon the completion of the injection. 
Increased 25-hydroxycholesterol percentages did not change specific bound mass of wt-
OSBP to 25-hydroxycholesterol containing bilayers. 
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Figure 32: Real time association of 1.0 µM of OSBP-S5E with DOPC bilayers of varying 
concentrations of oxysterol (2-20%). OSBP-S5E adsorbed quickly to 25-hydroxycholesterol 
containing bilayers upon injection of protein and quickly desorbed from 25-
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hydroxycholesterol containing membranes upon the completion of the injection. Increased 
25-hydroxycholesterol percentages did not change specific bound mass of OSBP-S5E to 25-
hydroxycholesterol containing bilayers. In comparison to wt-OSBP, these results are similar 
thus indicating that the behavior of OSBP-S5E is similar to wt-OSBP in the presence of 25-
hyroxycholesterol membranes.  
 
Figure 33: Maximum bound mass of 1.0 µM OSBP with increasing molecular percentage 
of ligand (PI(4)P, cholesterol and 25-hydroxycholesterol) in the adsorbed layer (courtesy of 
Parthajit Mukherjee). The maximum adsorbed mass of wt-OSBP increased as the 
concentration of PI(4)P in the lipid bilayer increased. The maximum adsorbed mass of 
OSBP, regardless of phosphorylation state, did not significantly differ as the concentration 
of sterol increased. However, OSBP, regardless of phosphorylation state, showed almost 2-
fold a greater adsorbed mass when bound to cholesterol in comparison to 25-
hydroxycholesterol.  
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3.7. Fluorescent Based Assays 
3.7.1. Binding Assay 
 Fluorescence binding assays that monitored the association of 22-NBD-cholesterol 
to 0.2 µM of OSBP were also attempted. Quadruplicates of wt-OSBP were monitored along 
with OSBP-S5E and a blank (i.e. no protein) sample (Figure 34). Upon examination, wt-
OSBP showed an increase in fluorescence intensity to a maximum of around 4500 counts 
with ~ 125 nM of 22-NBD cholesterol. The binding curve displayed by the wt-OSBP 
represented one-site binding. Due to the variability in the fluorescent intensity (± ~1000 
counts) for the wt-OSBP, the data was normalized and re-plotted; excluding OSBP-S5E as 
its intensity and trend was no different than that of the blank sample (Figure 35). OSBP-S5E 
showed a similar trend to the blank sample in which no change in fluorescence was observed 
suggesting that -22NBD-chcolesterol did not bind to S5E-OSBP. Hence, we conclude that 
OSBP-S5E does not bind 22-NBD-cholesterol. The data obtained were fit to a one-site 
binding non-linear regression using Prism (GraphPad, Inc) according to the equation below. 
Y = Bmax * X / (Kd + X) 
One-site binding, non-linear regression model where Y is the fluorescent intensity, Bmax is 
maximal binding, Kd is dissociation constant (concentration of ligand at which half-maximal 
binding is reached), and X is the concentration of ligand. A dissociation constant, Kd, of 15 
± 1.4 nM for 22-NBD-cholesterol binding to wt-OSBP was determined. 
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Figure 34: Binding assay of wt-OSBP and OSBP-S5E with 22-NBD-cholesterol using 
fluorescent at 537 nm and one site non-linear regression model (Prism, GraphPad). The 
quadruplicates of wt-OSBP showed significant variability in the recorded fluorescence, 
resulting in large error bars (± ~1000 counts) of the fluorescent intensity. The binding 
behavior of OSBP-S5E was similar to the blank sample with fluorescent intensity of <1500 
counts.   
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Figure 35: Normalized fluorescence data for the binding assay of wt-OSBP (in 
quadruplicate) with 22-NBD-cholesterol using fluorescence at 537 nm and one site non-
linear regression model (Prism, GraphPad). The quadruplicates of wt-OSBP showed a 
similar behavior to that of a one site binding non-linear regression model but with smaller 
variability in the error bars (± ~0.1) of the fluorescent intensity.  
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4. CONCLUSION AND FUTURE DIRECTIONS 
 The proposed mechanism (15) of OSBP as a PIP-sterol transport/exchanger and the 
localization of OSBP at the Golgi through its phosphorylation state, prompted us to explore 
OSBP’s binding behavior to different lipid compositions. Both wt-OSBP and the 
phosphomimic OSBP-S5E were looked at. Using dual polarization interferometry, DOPC 
lipid bilayers with different compositions of PI(4)P and sterols (cholesterol and 25-
hydroxycholesterol) were immobilized and the binding behavior of OSBP was examined in 
real time. Using a fluorescence-based binding assay, OSBP’s binding affinity to 22-NBD-
cholesterol was also examined.  
 The results obtained from the DPI tests revealed that wt-OSBP quickly adsorbs to 
PI(4)P containing membranes followed by a gradual desorption. This distinct behavior likely 
indicates that wt-OSBP was extracting PI(4)P and subsequently leaving the lipid bilayer. 
This distinct behavior was absent in all other tests performed using the phosphomimic 
mutant OSBP-S5E either with PI4P or either of the sterols used. The absence of such binding 
behavior, i.e. the rapid increase and the formation of a peak followed by a gradual decrease 
binding behavior, in the case of OSBP-S5E and PI(4)P containing membrane suggested that 
the phosphorylation of OSBP may prevent the recognition and/or extraction of PI(4)P.  
In the presence of sterols, the overall binding behavior of OSBP, regardless of 
phosphorylation state, was fairly similar. The maximum specific bound mass of OSBP to 
sterol containing bilayers did not change as the concentration of sterols increased. However, 
comparing the maximum specific bound mass of OSBP to cholesterol containing bilayers 
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with oxysterol (25-hydroxycholesterol) contining bilayers, OSBP displayed nearly a 2-fold 
increase in bound mass.  
In addition, the ligand recognition ability of OSBP was further tested using a 
fluorescence-based binding assay. Using 22-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-
23,24-bisnor-5-cholen-3β-ol (22-NBD cholesterol), wt-OSBP displayed a one site binding 
behaviour with a dissociation constant Kd, of 15 ± 1.4 nM. OSBP-S5E did not bind well to 
22-NBD cholesterol and the fluorescence intensity was similar to that of a blank sample 
(<1500 counts). 
For future directions, it is suggested to first perform additional tests to confirm the 
extraction of PI(4)P by wt-OSBP using either mass spectrometry or anti-PI(4)P antibodies. 
Effluent leaving the DPI machine can be collected and assessed or, better yet, after a test of 
wt-OSBP on PI(4)P containing membrane using the DPI, the chip holding the immobilized 
lipid bilayer can be taken out of the machine and then the remaining lipid bilayer removed. 
The recovered lipids can then be tested for the presence (or lack) of PI(4)P which should be 
the case if wt-OSBP was extracting PI(4)P lipids.  
In addition, further replicates of the protein-lipid binding assays using OSBP-S5E 
are needed. The results of OSBP-S5E stated here were reported after one or two tests were 
made. A minimum of three replicates, such was the case of wt-OSBP, are needed to better 
and more accurately report the results.  
It is also important to perform protein lipid binding assays using the DPI in which 
OSBP is pre-incubated with PI(4)P or sterol and see if the OSBP can exchange that ligand 
if exposed to sterol or PI(4)P containing membrane. Assuming that the OSBP does not 
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require any helper proteins (in the case of wt-OSBP and PI(4)P), the exchange of a sterol 
with PI(4)P should be observed in the case of a pre-incubated wt-OSBP with cholesterol 
being exposed to PI(4)P containing membrane. If this was the case, the binding behavior 
through real time, i.e. the DPI curve, should look similar to that of when a ligand is being 
extracted (e.g. the DPI curve of wt-OSBP and PI(4)P containing membranes).  
Additional fluorescence based assays with 22-NBD cholesterol can be performed in 
which Förster resonance energy transfer (FRET) in a FRET transfer assay can be looked at. 
Pre-incubating OSBP with 22-NBD-cholesterol and mixing the complex with a vesicle 
population containing a fluorescence quencher can show if OSBP can transfer 22-NBD-
cholesterol into lipid vesicles.  
In conclusion, wt-OSBP and OSBP-S5E bound in a similar fashion to sterol-
containing lipid bilayers. On the other hand, in the presence of PI(4)P-containing lipid 
bilayers, the wt-OSBP bound differently. We suspect that PI(4)P is extracted by wt-OSBP, 
however, this needs to be further examined and confirmed. Relating all of this to the bigger 
picture and the proposed pathway, we suspect that phosphorylation is the facilitator in the 
process of PI(4)P lipid extraction. However, it is still unclear what the role of 
phosphorylation of OSBP is in the presence of sterols.  
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